Questions and Answers in 2008 about Biologics in Rheumatoid ArthritisWEINBLATT, Michael E.Journal of rheumatology. 2008, Vol 35, Num 9, pp 1878-1881, issn 0315-162X, 4 p.Article

Rheumatoid arthritisLEE, David M; WEINBLATT, Michael E.Lancet (British edition). 2001, Vol 358, Num 9285, pp 903-911, issn 0140-6736Article

Radical intervention in early rheumatoid arthritis. The case for enteric-coated sulphasalazine, methotrexate and combination regimens. WorkshopVAN DE PUTTE, Leo B. A; WEINBLATT, Michael E.British journal of rheumatology. 1995, Vol 34, issn 0263-7103, 116 p., SUP2Conference Proceedings

Drug-induced Lupus Associated With Infliximab and Adalimumab in an Adolescent With Crohn DiseaseZELLA, Garrett C; WEINBLATT, Michael E; WINTER, Harland S et al.Journal of pediatric gastroenterology and nutrition. 2009, Vol 49, Num 3, pp 355-358, issn 0277-2116, 4 p.Article

Rituximab as therapy for refractory polymyositis and dermatomyositisNOSS, Erika H; HAUSNER-SYPEK, Dorota L; WEINBLATT, Michael E et al.Journal of rheumatology. 2006, Vol 33, Num 5, pp 1021-1026, issn 0315-162X, 6 p.Article

Therapeutic approaches for early rheumatoid arthritis. How early ? How aggressive ?EMERY, P.British journal of rheumatology. 1995, Vol 34, pp 87-90, issn 0263-7103, SUP2Conference Paper

Serious liver disease in a patient receiving methotrexate and leflunomideWEINBLATT, Michael E; DIXON, Jonathan A; FALCHUK, Kenneth R et al.Arthritis and rheumatism. 2000, Vol 43, Num 11, pp 2609-2611, issn 0004-3591Article

Clinical trial design for evaluating combination therapiesPAULUS, H. E.British journal of rheumatology. 1995, Vol 34, pp 92-95, issn 0263-7103, SUP2Conference Paper

Overview of combination second-line or disease-modifying antirheumatic drug therapy in rheumatoid arthritisWILLIAMS, H. J.British journal of rheumatology. 1995, Vol 34, pp 96-99, issn 0263-7103, SUP2Conference Paper

Sulphasalazine : mechanism of action in rheumatoid arthritisSMEDEGARD, G; BJÖRK, J.British journal of rheumatology. 1995, Vol 34, pp 7-15, issn 0263-7103, SUP2Conference Paper

How and when should combination therapy be used ? The role of an anchor drugFARR, M; BACON, P. A.British journal of rheumatology. 1995, Vol 34, pp 100-103, issn 0263-7103, SUP2Conference Paper

The history of the use of sulphasalazine in rheumatologyAMOS, R. S.British journal of rheumatology. 1995, Vol 34, pp 2-6, issn 0263-7103, SUP2Conference Paper

Agreement between patient report and medical record review for medications used for rheumatoid arthritis : The accuracy of self-reported medication information in patient registriesSOLOMON, Daniel H; STEDMAN, Margaret; LICARI, Andrea et al.Arthritis care and research. 2007, Vol 57, Num 2, pp 234-239, issn 0893-7524, 6 p.Article

Efficacy of methotrexate in rheumatoid arthritisWEINBLATT, M. E.British journal of rheumatology. 1995, Vol 34, pp 43-48, issn 0263-7103, SUP2Conference Paper

Practical clinical pharmacology and drug interactions of low-dose methotrexate therapy in rheumatoid arthritisFURST, D. E.British journal of rheumatology. 1995, Vol 34, pp 20-25, issn 0263-7103, SUP2Conference Paper

The antirheumatic agents sulphasalazine and methotrexate share and anti-inflammatory mechanismCRONSTEIN, B. N.British journal of rheumatology. 1995, Vol 34, pp 30-32, issn 0263-7103, SUP2Conference Paper

A Functional RANKL Polymorphism Associated With Younger Age at Onset of Rheumatoid ArthritisWENFENG TAN; HUI WU; MORELAND, Larry W et al.Arthritis and rheumatism. 2010, Vol 62, Num 10, pp 2864-2875, issn 0004-3591, 12 p.Article

Tumor necrosis factor-a antagonist use and heart failure in elderly patients with rheumatoid arthritisSETOGUCHI, Soko; SCHNEEWEISS, Sebastian; AVORN, Jerry et al.The American heart journal. 2008, Vol 156, Num 2, pp 336-341, issn 0002-8703, 6 p.Article

Peripheral blood expression of nuclear factor-κB-regulated genes is associated with rheumatoid arthritis disease activity and responds differentially to anti-tumor necrosis factor-α versus methotrexatePARKER, Alex; IZMAILOVA, Elena S; WEINBLATT, Michael E et al.Journal of rheumatology. 2007, Vol 34, Num 9, pp 1817-1822, issn 0315-162X, 6 p.Article

Etanercept treatment in adults with established rheumatoid arthritis : 7 years of clinical experienceMORELAND, Larry W; WEINBLATT, Michael E; KEYSTONE, Edward C et al.Journal of rheumatology. 2006, Vol 33, Num 5, pp 854-861, issn 0315-162X, 8 p.Article

Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-Term (MEDAL) programme : a randomised comparison. CommentaryGARCIA RODRIGUEZ, Luis Alberto; PATRIQNANI, Paola; WEINBLATT, Michael E et al.Lancet (British edition). 2006, Vol 368, Num 9549, issn 0140-6736, 1745-1747,1771-1781 [14 p.]Article

Efficacy, pharmacokinetic, and safety assessment of adalimumab, a fully human anti-tumor necrosis factor-alpha monoclonal antibody, in adults with rheumatoid arthritis receiving concomitant methotrexate: A pilot studyWEISMAN, Michael H; MORELAND, Larry W; FISCHKOFF, Steven A et al.Clinical therapeutics. 2003, Vol 25, Num 6, pp 1700-1721, issn 0149-2918, 22 p.Article

Long-term usage and side-effect profile of sulphasalazine in rheumatoid arthritisVAN RIEL, P. L. C. M; VAN GESTEL, A. M; VAN DE PUTTE, L. B. A et al.British journal of rheumatology. 1995, Vol 34, pp 40-42, issn 0263-7103, SUP2Conference Paper

De novo copy number variants identify new genes and loci in isolated sporadic tetralogy of FallotGREENWAY, Steven C; PEREIRA, Alexandre C; GORHAM, Joshua M et al.Nature genetics. 2009, Vol 41, Num 8, pp 931-935, issn 1061-4036, 5 p.Article

Investigation of candidate polymorphisms and disease activity in rheumatoid arthritis patients on methotrexateLEE, Yvonne C; JING CUI; COSTENBADER, Karen H et al.Rheumatology (Oxford. Print). 2009, Vol 48, Num 6, pp 613-617, issn 1462-0324, 5 p.Article